Lv2
120 积分 2022-05-26 加入
小分子TKI治疗HER2+乳腺癌脑转移研究进展
2天前
已完结
安罗替尼在铂耐药卵巢癌中的疗效与安全性观察及预后标志物的探索
16天前
已完结
抗血管生成药物在铂耐药卵巢癌中的应用进展
16天前
已完结
抗体偶联药物治疗铂耐药卵巢癌的研究进展
16天前
已完结
MP38-16 JUSTIFICATION OF 8TH EDITION AJCC TUMOR NODE METASTASIS UPDATES FOR BLADDER CANCER STAGING
1个月前
已关闭
MP38-16 JUSTIFICATION OF 8TH EDITION AJCC TUMOR NODE METASTASIS UPDATES FOR BLADDER CANCER STAGING
1个月前
已关闭
MP38-16 JUSTIFICATION OF 8TH EDITION AJCC TUMOR NODE METASTASIS UPDATES FOR BLADDER CANCER STAGING
1个月前
已关闭
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
1个月前
已完结
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
1个月前
已完结
皖公网安备34019202002308
